EPIC Enzymes Pharmaceuticals & Indl. Chemicals Ltd - Stock Valuation and Financial Performance

BSE: 524374 | NSE: | Pesticides & Agrochemicals | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on EPIC Enzymes Pharma

M-Cap below 100cr DeciZen not available

EPIC Enzymes Pharmaceuticals & Indl. Chemicals stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
1.5 Cr.
52-wk low:
1.7
52-wk high:
1.9

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of EPIC Enzymes Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Jun'03Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12TTM
ROCE % 1.1%4.2%0.1%-8.6%-18.7%-30.6%-10.1%-5.3%-44.1%-6.4%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 13.718.316.811.58.66.51.90.10.200
Sales YoY Gr.-33.5%-8%-31.5%-25.4%-24.4%-70.6%-93.7%83.3%-100%-
Adj EPS -0.70.7-0.9-4.1-7.7-10.9-2.4-1.3-8.9-0.3-0.3
YoY Gr.-NA-227.1%NANANANANANANA-
BVPS (₹) 14.422.415.812.56.5-3.7-6.1-7.2-22.7-22.9-22.8
Adj Net
Profit
-0.60.6-0.8-3.5-6.6-9.3-2.1-1.1-7.7-0.20
Cash Flow from Ops. 0.41.3-3-6.4-0.9-3.21-0.21.8-0.9-
Debt/CF from Ops. 26.410.2-4.4-3.2-21.6-7.121.4-100.612.7-24.2-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -100%-100%-100%-100%
Adj EPS NANANANA
BVPS-205.2%-228.7%NANA
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Jun'03Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12TTM
Return on
Equity %
-4.53.2-5.2-27-72-439.262.52262.91.21.2
Op. Profit
Mgn %
5.79.2-14-33.5-48.8-95.8-82.8-476.8-458.70NAN
Net Profit
Mgn %
-4.23.3-4.6-30.6-77.1-143.6-109.8-938.6-3445.50-INF
Debt to
Equity
0.80.711.93.6-7.2-4.2-3.6-1.2-1.2-
Working Cap
Days
21724726443856349077913,6596,16200
Cash Conv.
Cycle
3558931823233474235,0131,44800

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - EPIC Enzymes Pharmaceuticals & Indl. Chemicals Ltd.

Standalone Consolidated
TTM EPS (₹) -0.3 -
TTM Sales (₹ Cr.) 0 -
BVPS (₹.) -22.8 -
Reserves (₹ Cr.) -28 -
P/BV -0.08 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 1.71 / 1.87
All Time Low / High (₹) 1.43 / 82.40
Market Cap (₹ Cr.) 1.5
Equity (₹ Cr.) 8.6
Face Value (₹) 10
Industry PE 36.1

Management X-Ray of EPIC Enzymes Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of EPIC Enzymes Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSJun'03Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12
Sales13.7013.7116.8311.538.606.501.910.120.220
Operating Expenses 12.9312.4519.1915.4312.7912.843.540.671.240.18
Manufacturing Costs2.542.223.162.341.461.510.440.1200
Material Costs7.457.5313.089.965.2810.172.110.220.990
Employee Cost 1.120.741.111.310.490.190.130.060.010
Other Costs 1.811.971.831.815.570.960.860.280.230.18
Operating Profit 0.781.26-2.36-3.89-4.20-6.34-1.63-0.55-1.02-0.18
Operating Profit Margin (%) 5.7%9.2%-14.0%-33.8%-48.8%-97.4%-85.4%-476.0%-458.0%-
Other Income 1.512.243.072.012.401.310.200.132.020.01
Interest 1.150.791.151.351.563.140.280.274.560
Depreciation 0.820.950.910.780.780.650.420.410.060.06
Exceptional Items 000000-0.010.03-10.420
Profit Before Tax 0.321.76-1.36-4.01-4.14-8.81-2.13-1.07-14.03-0.23
Tax 0-0.11-0.59-1.621.190.010000
Profit After Tax 0.321.86-0.77-2.39-5.33-8.82-2.14-1.07-14.03-0.23
PAT Margin (%) 2.3%13.6%-4.6%-20.7%-62.0%-135.0%-112.0%-918.0%-6,322.1%-
Adjusted EPS (₹)0.42.2-0.9-2.8-6.2-10.3-2.5-1.2-16.4-0.3
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSJun'03Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12

Equity and Liabilities

Shareholders Fund 13.1615.0314.2511.866.53-2.28-4.42-5.49-18.81-19.04
Share Capital 8.578.578.578.578.578.578.578.578.578.57
Reserves 4.596.465.683.29-2.04-10.85-12.99-14.06-27.38-27.61
Minority Interest0000000000
Debt10.209.5613.3420.7519.8922.5121.9122.1422.3422.63
Long Term Debt10.209.5613.3420.7519.8922.5121.9122.1422.3422.63
Short Term Debt0000000000
Trade Payables4.593.996.324.372.640.990.990.991.691.58
Others Liabilities 1.271.880.47-1.020.470.970.803.990.110.11
Total Liabilities 29.2130.4534.3835.9629.5322.1919.2821.655.345.28

Fixed Assets

Gross Block26.4726.9327.2427.1628.2728.2728.2428.2422
Accumulated Depreciation8.679.5810.4911.2212.0112.6513.0513.460.600.66
Net Fixed Assets17.8017.3516.7515.9416.2715.6215.1914.781.401.34
CWIP 0.14001.1100000.400.40
Investments 0.130.130.130.130.120.120.400.120.120.12
Inventories5.756.3910.2610.667.742.491.871.650.670.67
Trade Receivables0.741.130.561.862.171.870.040.170.020.01
Cash Equivalents 2.182.292.612.580.720.200.070.080.920.28
Others Assets2.473.174.083.692.521.881.704.841.802.45
Total Assets 29.2130.4534.3835.9629.5322.1919.2821.655.345.28

Cash Flow

(All Figures are in Crores.)
PARTICULARSJun'03Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12
Cash Flow From Operating Activity 0.390.94-3-6.41-0.92-3.161.02-0.221.76-0.94
PBT 0.321.75-1.36-4.020.20-8.81-2.12-1.07-3.61-0.23
Adjustment 1.481.401.822.362.373.890.770.414.670.12
Changes in Working Capital -0.75-1.65-2.63-2.673.64.92.380.080.7-0.83
Tax Paid 0-0.110-0.01-0.02-0.010000
Cash Flow From Investing Activity -0.38-0.20-0.47-1.020.160.01-0.270-2.650.01
Capex -0.26-0.36-0.31-1.170000-2.670
Net Investments -0.310-0.2900-0.02-0.27000
Others 0.190.150.140.150.170.03000.020.01
Cash Flow From Financing Activity 1.72-0.643.797.41-1.112.62-0.870.231.600.28
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0-0.6400000000
Interest Paid 0000000000
Dividend Paid 0000000000
Others 1.7203.797.41-1.112.62-0.870.231.600.28
Net Cash Flow 1.730.100.32-0.03-1.86-0.53-0.120.010.71-0.64
PARTICULARSJun'03Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12
Ratios
ROE (%)2.6113.94-5.52-19.75-65.6N/AN/AN/AN/AN/A
ROCE (%)6.8510.94-0.81-9.12-9.05N/AN/AN/AN/AN/A
Asset Turnover Ratio0.50.470.530.350.270.250.10.010.020
PAT to CFO Conversion(x)1.220.51N/AN/AN/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days28251835831131683011350
Inventory Days1411591773073822873825,0911,6920
Payable Days238208144196242651711,6474330

EPIC Enzymes Pharmaceuticals & Indl. Chemicals Ltd Stock News

EPIC Enzymes Pharmaceuticals & Indl. Chemicals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of EPIC Enzymes Pharma on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of EPIC Enzymes Pharma stood at ₹1.47.
The latest P/E ratio of EPIC Enzymes Pharma as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of EPIC Enzymes Pharma as of 01-Jan-1970 05:30 is -0.08.
The 52-week high of EPIC Enzymes Pharma is ₹1.87 and the 52-week low is ₹1.71.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of EPIC Enzymes Pharma is ₹0.00 ( Cr.) .

About EPIC Enzymes Pharmaceuticals & Indl. Chemicals Ltd

Epic Enzymes Pharmaceuticals & Industrial Chemicals was incorporated on November 2, 1982 under the Companies Act in 1956 in Maharashtra as a private limited company, which was converted to a public limited company on November 6, 1992, by a special resolution of the general meeting of the company. The company was originally promoted by Ratanshaw Elavia and K N Nikorawalla. The company has entered into a technical and financial collaboration with Feinchemie Schewebda GmbH.

Epic Enzymes specialises in organic chemicals, pesticides and herbicides. The company`s registered office is located in Vashi, Navi Mumbai, Maharashtra. Its factory is located at Plot No. 32, VRDIC, Vithoba Industrial Complex, Village Lohop, post Mazgaon, taluka Khalapur, district Raigad, Maharashtra. Installed capacity of the company is 800 MT per annum.

Business areas of the company:

The company is engaged in the agrochemical business. The agrochemical industry consists of various products in different segments like insecticides, fungicides, weedicides, herbicides, and rodenticides. Raw materials that are used to manufacture agrochemicals are food grains and commercial crops.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.